Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The company plans to submit orforglipron for approval as an obesity medication to global regulatory agencies by the end of the year, and as a diabetes medication in 2026
Per injection: 2 swabs 16 weeks (once weekly): ~32 swabs 1 box Dosing Protocol Cycle Length: Typically ~16 weeks or longer, depending on research goals
The pre-release window is the highest-leverage time in the entire SBIR cycle
Storage & Handling: AOD 9604 should be kept in dry conditions at low temperatures in protection from sunlight or heat rays
The study conforms to the ethical guidelines of the 1975 Declaration of Helsinki
Specificity is as follows for the reactive species: H:T472, M:T472, R:T472
US$ 23.33
US$ 27.14
US$ 20.55
US$ 21.93
US$ 25.21
US$ 24.09
US$ 24.30
US$ 23.50
US$ 22.49
